Barclays’s Perspective Therapeutics CATX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $355K | Buy |
103,281
+45,388
| +78% | +$156K | ﹤0.01% | 3217 |
|
|
2025
Q1 | $123K | Sell |
57,893
-36,986
| -39% | -$78.6K | ﹤0.01% | 3600 |
|
|
2024
Q4 | $302K | Sell |
94,879
-19,196
| -17% | -$61.1K | ﹤0.01% | 3327 |
|
|
2024
Q3 | $1.52M | Buy |
114,075
+97,493
| +588% | +$1.3M | ﹤0.01% | 2373 |
|
|
2024
Q2 | $165K | Buy |
16,582
+9,681
| +140% | +$96.3K | ﹤0.01% | 3144 |
|
|
2024
Q1 | $82K | Buy |
+6,901
| New | +$82K | ﹤0.01% | 3708 |
|
|
2021
Q2 | – | Sell |
-174
| Closed | -$2K | – | 4081 |
|
|
2021
Q1 | $2K | Buy |
+174
| New | +$2K | ﹤0.01% | 3821 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 4202 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 4210 |
|